Azithromycin (Zithromax, Z-Pack) is a macrolide antibiotic used for respiratory infections, skin infections, chlamydia, and community-acquired pneumonia. It works by binding to the bacterial 50S ribosomal subunit and blocking protein synthesis; its tissue half-life of ~68 hours allows effective short 5-day treatment courses. Common side effects include nausea, diarrhea, and abdominal pain. The key warning is QT interval prolongation, which can trigger potentially fatal cardiac arrhythmias — patients with cardiac risk factors require careful screening before use.
Azithromycin
Azithromycin is a macrolide antibiotic commonly prescribed for respiratory, skin, and sexually transmitted infections. Its uniquely long tissue half-life allows for shorter treatment courses than most other antibiotics, making the Z-Pack (a 5-day course) one of the most recognizable antibiotic regimens in medicine.
Uses & FDA Indications
Azithromycin is FDA-approved for a broad range of bacterial infections in adults and children. Its spectrum covers many atypical organisms that other antibiotics miss.
- Community-acquired pneumonia (CAP) — mild to moderate severity in outpatient settings
- Acute bacterial exacerbations of COPD
- Pharyngitis and tonsillitis — due to Streptococcus pyogenes (as alternative to penicillin)
- Sinusitis — acute bacterial sinusitis in adults
- Skin and soft tissue infections — uncomplicated infections
- Sexually transmitted infections — chlamydia (Chlamydia trachomatis); used in gonorrhea combination regimens
- Pelvic inflammatory disease (PID) — as part of combination therapy
- Mycobacterium avium complex (MAC) — prevention and treatment in HIV patients
- Otitis media — acute ear infections in children
How It Works
Azithromycin belongs to the azalide subclass of macrolide antibiotics. Unlike penicillins that attack the bacterial cell wall, azithromycin targets the bacterial ribosome — the cellular machinery responsible for making proteins.
Specifically, azithromycin binds reversibly to the 50S ribosomal subunit (the 23S rRNA component) and blocks the translocation step of protein synthesis. Without functioning ribosomes, bacteria cannot produce the proteins needed for growth, reproduction, and survival.
Azithromycin is primarily bacteriostatic (inhibits growth) but can be bactericidal at higher concentrations. Its extraordinary tissue penetration — achieving concentrations up to 100 times higher in tissues than in blood — explains why short courses remain effective for days after the last dose.
Azithromycin also has clinically meaningful anti-inflammatory properties, which may contribute to its effectiveness in respiratory conditions beyond pure antibacterial activity. It can suppress production of pro-inflammatory cytokines and reduce neutrophil accumulation.
Side Effects
Common
- Nausea (most frequent GI complaint)
- Diarrhea or loose stools
- Abdominal pain or cramping
- Vomiting
- Headache
- Dizziness
Serious
- QT prolongation / cardiac arrhythmia — azithromycin can prolong the QT interval, increasing risk of potentially fatal arrhythmias (torsades de pointes); this is the most significant safety concern
- Hypersensitivity reactions — including anaphylaxis, angioedema, and Stevens-Johnson syndrome
- Hepatotoxicity — abnormal liver function, cholestatic jaundice (rare)
- C. difficile colitis — antibiotic-associated diarrhea; may occur weeks after treatment
- Sensorineural hearing loss — rare, particularly with prolonged use or high cumulative doses
- Myasthenia gravis exacerbation — macrolides can worsen this condition
Drug Interactions
| Drug / Class | Interaction | Clinical Significance |
|---|---|---|
| QT-prolonging drugs (antipsychotics, antiarrhythmics, fluoroquinolones) | Additive QT prolongation; increased risk of fatal arrhythmia | High — avoid combination when possible |
| Warfarin | May potentiate anticoagulant effect; mechanism not fully established | Moderate — monitor INR |
| Digoxin | Macrolides can raise digoxin levels by altering gut flora that metabolizes digoxin | Moderate — monitor digoxin levels |
| Statins (simvastatin, lovastatin) | Azithromycin may increase statin levels via CYP3A4 inhibition, raising myopathy risk | Moderate — use lowest effective statin dose |
| Cyclosporine | Azithromycin can increase cyclosporine plasma levels, risking nephrotoxicity and other toxicities | High — monitor cyclosporine levels |
| Antacids (aluminum/magnesium) | Can reduce peak plasma concentration of azithromycin | Low — separate administration by 2 hours |
Warnings & Contraindications
⚠ BLACK BOX WARNING (historical): The FDA issued a safety communication warning that azithromycin can cause abnormal and potentially fatal heart rhythms. Patients with known QT prolongation, hypokalemia, hypomagnesemia, bradycardia, or those taking antiarrhythmic drugs are at greatest risk.
- Cardiac patients: Evaluate cardiac history before prescribing; obtain ECG if QT prolongation risk factors are present.
- Macrolide hypersensitivity: Contraindicated in patients with known hypersensitivity to azithromycin, erythromycin, or any macrolide antibiotic.
- Hepatic impairment: Use with caution; azithromycin is primarily eliminated by biliary excretion. Avoid in severe liver disease.
- Myasthenia gravis: Azithromycin and other macrolides have been associated with acute exacerbations of myasthenia gravis and new-onset symptoms. Avoid if possible.
- Antibiotic resistance: Azithromycin resistance among Streptococcus pneumoniae and Neisseria gonorrhoeae is increasing significantly; confirm susceptibility when possible.
FAQ
Why does the Z-Pack only last 5 days if the infection might need longer treatment?
Azithromycin has an exceptionally long tissue half-life of approximately 68 hours. Drug concentrations in tissues (lungs, tonsils, lymph nodes) remain at therapeutically active levels for up to 10 days after the last dose, even though blood levels drop faster. This pharmacokinetic property is what makes short Z-Pack courses clinically effective.
Can azithromycin treat COVID-19 or the flu?
No. Azithromycin is an antibacterial agent with no direct antiviral activity against SARS-CoV-2 or influenza viruses. Large clinical trials have definitively shown it is not effective for COVID-19 treatment. It may sometimes be prescribed concurrently if a secondary bacterial infection is suspected, but not for the viral illness itself.
Is azithromycin safe during pregnancy?
Azithromycin is classified as Pregnancy Category B, meaning animal studies have not shown fetal harm but adequate human studies are limited. It is generally considered one of the safer antibiotics during pregnancy, particularly for treating chlamydia and respiratory infections when penicillins cannot be used. Always inform your provider if you are pregnant or planning to become pregnant.
Why am I being asked about heart problems before being prescribed azithromycin?
Azithromycin can prolong the QT interval — an electrical measurement of heart rhythm. In some individuals, this can trigger dangerous arrhythmias. Providers screen for risk factors (prior cardiac arrhythmia, low potassium or magnesium, other QT-prolonging medications) before prescribing. If you have heart disease or take heart medications, make sure your provider is aware.
Need to identify an azithromycin tablet by its imprint, shape, or color?
Use the PillID Pill Identifier →